Related Experiment Video
Updated: Jan 17, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Using Dexcom G7 in Critically Ill Infant With Hyperinsulinemia on High Frequency Oscillatory Ventilation Support
Chad E Ward1, Timothy Clark1, Eric Velazquez1
1Memorial Health University Medical Center, Savannah, Georgia.
Insights
Continuous glucose monitors (CGMs) like the Dexcom G7 can safely detect hypoglycemia in critically ill infants on mechanical ventilation. This technology aids in managing blood sugar and reducing necessary blood tests in intensive care settings.
Area of Science:
- Pediatric Critical Care
- Neonatal Medicine
- Medical Technology
Background:
- Life-threatening hypoglycemia is a risk for infants with hyperinsulinemia or metabolic disorders during critical illness.
- Continuous glucose monitoring (CGM) offers insights into glycemic trends in high-risk infants in intensive care units (ICUs).
- Barriers to CGM use in ICUs include staff familiarity, safety concerns, and cost.
Introduction:
Life threatening hypoglycemia can occur during critical illness in infants with underlying hyperinsulinemia or metabolic conditions, such as glycogen storage diseases. Using a continuous glucose monitor (CGM) can provide insight into glycemic trends with this high-risk patient population in the intensive care setting. Barriers to usage of CGMs in the intensive care unit include familiarity with CGMs devices among staff, safety, and cost.
Case Presentation:
We describe the first reported case of safely utilizing the newest Dexcom G7 continuous glucose monitor in an infant with hyperinsulinemia undergoing high frequency oscillatory ventilator (HFOV) support for acute respiratory distress syndrome (ARDS) to detect early hypoglycemic episodes during critical illness while on continuous glucose infusion.
Conclusion:
There is limited information on using the Dexcom G7 CGM device in infants with underlying hypoglycemic conditions on HFOV support. The use of HFOV poses a unique physiological challenge for using a CGM device. We demonstrate that the Dexcom G7 is safe to use while on HFOV. The device provided important glycemic trends, which helped to reduce the number of point-of-care tests and allowed for early detection of hypoglycemia.
More Related Videos
09:31Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism
Published on: February 14, 2022
14:28Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care
Published on: May 10, 2024
Related Concept Videos
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation I: Indication and Settings
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Acute Respiratory Failure-IV
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: